Cargando…

CD4(+) and CD8(+) T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy

Experimental aristolochic acid nephropathy is characterized by transient acute proximal tubule necrosis and inflammatory cell infiltrates followed by interstitial fibrosis and tubular atrophy. The respective role of T-cell subpopulations has never been studied in the acute phase of the mouse model,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baudoux, Thomas, Husson, Cécile, De Prez, Eric, Jadot, Inès, Antoine, Marie-Hélène, Nortier, Joëlle L., Hougardy, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871862/ https://www.ncbi.nlm.nih.gov/pubmed/29593222 http://dx.doi.org/10.1038/s41598-018-23565-2

Ejemplares similares

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature
por: Jadot, Inès, et al.
Publicado: (2017)

Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy
por: Jadot, Inès, et al.
Publicado: (2017)

Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells
por: Antoine, Marie-Hélène, et al.
Publicado: (2022)

The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
por: Sborchia, Mateja, et al.
Publicado: (2019)

Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts
por: Lablad, Yahya, et al.
Publicado: (2023)

Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats
por: Pozdzik, Agnieszka A., et al.
Publicado: (2016)

Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers
por: Bunel, Valérian, et al.
Publicado: (2017)

Circulating (CD3(−)CD19(+)CD20(−)IgD(−)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
por: Pozdzik, Agnieszka, et al.
Publicado: (2016)

Nephroprotective Effects of Two Ganoderma Species Methanolic Extracts in an In Vitro Model of Cisplatin Induced Tubulotoxicity
por: Sinaeve, Sébastien, et al.
Publicado: (2022)

Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
por: Premužić, Vedran, et al.
Publicado: (2018)

Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
por: Yi, Joo-Hark, et al.
Publicado: (2018)

«Suspects» in Etiology of Endemic Nephropathy: Aristolochic Acid versus Mycotoxins
por: Pepeljnjak, Stjepan, et al.
Publicado: (2010)

Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy
por: Tseng, Chiao-Shih, et al.
Publicado: (2011)

Smad7 protects against chronic aristolochic acid nephropathy in mice
por: Dai, Xiao-Yu, et al.
Publicado: (2015)

Protective Effects of Melatonin Against Aristolochic Acid-Induced Nephropathy in Mice
por: Kim, Jung-Yeon, et al.
Publicado: (2019)

Growing risk of aristolochic acid nephropathy in the era of COVID-19 – Correspondence
por: Das, Tuyelee, et al.
Publicado: (2022)

Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis
por: Sasaki, Kensuke, et al.
Publicado: (2022)

Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice
por: Dai, Xiao Y., et al.
Publicado: (2016)

Blockade of the mTOR signaling pathway with rapamycin ameliorates aristolochic acid nephropathy
por: Wu, Minmin, et al.
Publicado: (2020)

Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
por: Ishii, Takeo, et al.
Publicado: (2021)

CD8(+) T Regulatory Cells in Lupus
por: Singh, Ram P., et al.
Publicado: (2021)

CD28(−) and CD28(low)CD8(+) Regulatory T Cells: Of Mice and Men
por: Vuddamalay, Yirajen, et al.
Publicado: (2017)

Renal Protective Effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy
por: Shi, Min, et al.
Publicado: (2016)

Aristolochic acid nephropathy: A scientometric analysis of literature published from 1971 to 2019
por: Ji, Hongjian, et al.
Publicado: (2021)

Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells
por: Gilliet, Michel, et al.
Publicado: (2002)

Lenalidomide overcomes the immunosuppression of regulatory CD8(+)CD28(−) T-cells
por: Neuber, Brigitte, et al.
Publicado: (2017)

Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma
por: Zhang, Qunfang, et al.
Publicado: (2020)

PD-L1(+)CD8(+) T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance
por: Zheng, Yingxia, et al.
Publicado: (2022)

Regulatory CD4(+)CD25(+) T Cells Restrict Memory CD8(+) T Cell Responses
por: Kursar, Mischo, et al.
Publicado: (2002)

CD28 engagement inhibits CD73-mediated regulatory activity of CD8(+) T cells
por: Lai, Yo-Ping, et al.
Publicado: (2021)

Bioinformatics facilitating the use of microarrays to delineate potential miRNA biomarkers in aristolochic acid nephropathy
por: Lv, Yana, et al.
Publicado: (2016)

Integrative microRNA and mRNA expression profiling in acute aristolochic acid nephropathy in mice
por: Zhu, Ziqiang, et al.
Publicado: (2020)

Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy
por: Kholia, Sharad, et al.
Publicado: (2020)

Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system
por: Wang, Yu, et al.
Publicado: (2022)

Renal angiotensin I-converting enzyme-deficient mice are protected against aristolochic acid nephropathy
por: Juretzko, Annett, et al.
Publicado: (2022)

Identification of Cytolytic CD161(−)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood
por: Hu, Dan, et al.
Publicado: (2013)

CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions
por: Laugel, Bruno, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ssgaa0kr44o5hur8km7imql1d3